Renalytix AI gets national Medicare pricing for 'KidneyIntelX' in US
3rd Dec 2019 09:33
(Sharecast News) - Artificial intelligence-enabled kidney disease diagnostics provider Renalytix AI announced on Tuesday that the Centers for Medicare and Medicaid Services (CMS) has released the final 2020 Clinical Laboratory Fee Schedule (CLFS), and has set a national price for its 'KidneyIntelX' test in the United States.
Read moreRenalytix AI gets preliminary Medicare pricing for 'KidneyIntelX'
30th Sep 2019 10:10
(Sharecast News) - Artificial intelligence-enabled kidney disease clinical diagnostics developer Renalytix AI announced on Monday that Centers for Medicare & Medicaid Services (CMS) has published its preliminary determination for national Medicare pricing for its 'KidneyIntelX' test, to be included in the national 2020 Clinical Laboratory Fee Schedule in the United States.
Read moreSunday share tips: CYBG, Renalytix AI
16th Jun 2019 15:00
(Sharecast News) - In her 'Inside the City' column for the Sunday Times, Emma Dunkley opened by lamenting the state of the challenger bank market, writing that instead of "shaking up" the Big Four, they had instead made an "underwhelming" impact, with Barclays, HSBC, Royal Bank of Scotland and Lloyds still dominating.
Read moreRenalytix AI begins clinical validation study for 'KidneyIntelX'
23rd Jan 2019 12:08
(Sharecast News) - Artificial intelligence-enabled kidney disease diagnostics developer Renalytix AI announced the start of its clinical validation study for its lead diagnostic, 'KidneyIntelX', on Wednesday.
Read more